Evidence Synthesis
MEDANTA's 52.55% has accelerated, up from 15.29%.
The company's .5% has decelerated, down from . MEDANTA's to .3 INR. The company's to . MEDANTA's to .
By paying you agree to our Terms and Privacy Policy.
Evidence Synthesis
Last synthesized: 8 Jul 2026, 14:38
Evidence Synthesis
MEDANTA's 52.55% has accelerated, up from 15.29%.
The company's .5% has decelerated, down from . MEDANTA's to .3 INR. The company's to . MEDANTA's to .
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 52.55 % | 15.29 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 15.29 % | 12.62 | ▲ |
| REVENUE_GROWTH_YOY | 24.5 % | 42 | ▼ |
| EPS_ACTUAL | 5.359 INR | 5.423 | ▼ |
| EPS_SURPRISE_PERCENT | 0.113 % | -0.096 | ▲ |
| PRICE_CHANGE_PERCENT | -1.08 % | — | - |
| DAILY_VOLUME | 1,47,443 shares | 2,48,799 | ▼ |
| CLOSE_PRICE | 1,310 INR | 1,324.3 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.88 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 4 count | 11 | ▼ |
| TARGET_PRICE_PREMIUM | 8.46 % | — | - |